Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 4, 2015, Pages 485-495

  Guichardant, Michel ^a   Calzada, Catherine ^a   Bernoud Hubac, Nathalie ^a   Lagarde, Michel ^a   Véricel, Evelyne ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Dioxygenases; Docosahexaenoic acid; Eicosapentaenoic acid; Peroxidation; Platelets; Linolenic acid

Indexed keywords

ACETAL DERIVATIVE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSANOID; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; LIPID; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; LINOLENIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; DRUG EFFICACY; EPOXIDATION; HUMAN; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIPIDOMICS; MEDIATOR; METABOLISM; METABOLITE; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; ANIMAL; DOSE RESPONSE; OXIDATION REDUCTION REACTION; RISK ASSESSMENT; TREATMENT OUTCOME;

ALPHA-LINOLENIC ACID; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; OXIDATION-REDUCTION; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84922582361     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.09.013     Document Type: Review

References (173)

1. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
2. I.H. Page, E.V. Allen, F.L. Chamberlain, A. Keys, J. Stamler, and F.J. Stare Dietary fat ant its relation to heart attacks and strokes Circulation 23 1961 133 136
3. H.O. Bang, and J. Dyerberg Plasma lipids and lipoproteins in Greenlandic west coast Eskimos Acta Med. Scand. 192 1972 85 94
4. J. Dyerberg, and H.O. Bang Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family Haemostasis 8 1979 227 233
5. D. Kromhout, E.B. Bosschieter, and C. de Lezenne Coulander The inverse relation between fish consumption and 20-year mortality from coronary heart disease N. Engl. J. Med. 312 1985 1205 1209
6. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
7. C. von Schacky, and P.C. Weber Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans J. Clin. Invest. 76 1985 2446 2450
8. J.N. Din, D.E. Newby, and A.D. Flapan Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment BMJ 328 2004 30 35
9. S.M. Kwak, S.K. Myung, Y.J. Lee, and H.G. Seo Korean Meta-analysis Study Group, Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials Arch. Intern. Med. 172 2012 686 694
10. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis JAMA 308 2012 1024 1033
11. A. Messori, V. Fadda, D. Maratea, and S. Trippoli ω-3 fatty acids supplements for secondary prevention of cardiovascular disease: from "no proof of effectiveness" to "proof of no effectiveness" JAMA Intern. Med. 173 2013 1466 1468
12. A. Grey, and M. Bolland Clinical trial evidence and use of fish oil supplements JAMA Intern. Med. 2014 460 462
13. B. Rauch, R. Schiele, S. Schneider, F. Diller, N. Victor, H. Gohlke, M. Gottwik, G. Steinbeck, U. Del Castillo, R. Sack, H. Worth, H. Katus, W. Spitzer, G. Sabin, J. Senges, and OMEGA Study Group OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
14. D. Kromhout, E.J. Giltay, and J.M. Geleijnse Alpha Omega Trial Group n-3 fatty acids and cardiovascular events after myocardial infarction N. Engl. J. Med. 363 2010 2015 2026
15. C. von Schacky Omega-3 fatty acids in cardiovascular disease - an uphill battle Prostaglandins Leukot. Essent. Fat. Acids May 28 2014 10.1016/j.plefa.2014.05.004 (pii: S0952-3278(14)00079-9)
16. M.C. de Oliveira Otto, J.H.Y. Wu, A. Baylin, D. Vaidya, S.S. Rich, M.Y. Tsai, D.R. Jacobs, and D. Mozaffarian Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic study of atherosclerosis J. Am. Heart Assoc. 2 2013 e000506
17. I.A. Brouwer, M.B. Katan, and P.L. Zock Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis J. Nutr. 134 2004 919 922
18. A. Pan, M. Chen, R. Chowdhury, J.H. Wu, Q. Sun, H. Campos, D. Mozaffarian, and F.B. Hu α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis Am. J. Clin. Nutr. 96 2012 1262 1273
19. E.W. Holy, M. Forestier, E.K. Richter, A. Akhmedov, F. Leiber, G.G. Camici, P. Mocharla, T.F. Luscher, J.H. Beer, and F.C. Tanner Dietary alpha-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation Arterioscler. Thromb. Vasc. Biol. 31 2011 1772 1780
20. L.S. Rallidis, G. Paschos, G.K. Liakos, A.H. Velissaridou, G. Anastasiadis, and A. Zampelas Dietary alpha-linolenic acid decreases c-reactive protein, serum amyloid a and interleukin-6 in dyslipidaemic patients Atherosclerosis 167 2003 237 242
21. G.C. Burdge, and P.C. Calder Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective Nutr. Res. Rev. 19 2006 26 52
22. S. Egert, F. Kannenberg, V. Somoza, H.F. Erbersdobler, and U. Wahrburg Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans J. Nutr. 139 2009 861 868
23. J.T. Brenna Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man Curr. Opin. Clin. Nutr. Metab. Care 5 2002 127 132
24. J.T. Brenna, N. Salem Jr., A.J. Sinclair, and S.C. Cunnane alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans Prostaglandins Leukot. Essent. Fat. Acids 80 2009 85 91
25. M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin, M. Lagarde, and M. Guichardant Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA J. Lipid Res. 54 2013 2083 2094
26. H.G. Wahl, C. Kausch, F. Machicao, K. Rett, M. Stumvoll, and H.U. Häring Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures Diabetes 5 2002 1060 1065
27. M.J. James, V.M. Ursin, and L.G. Cleland Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids Am. J. Clin. Nutr. 77 2003 1140 1145
28. M.E. Surette Dietary omega-3 PUFA and health: stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils Mol. Nutr. Food Res. 57 2013 748 759
29. V. Kockmann, D. Spielmann, H. Traitler, and M. Lagarde Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation Lipids 24 1989 1004 1007
30. M.E. Surette, M. Edens, F.H. Chilton, and K.M. Tramposch Dietary echium oil increases plasma and neutrophil longchain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans J. Nutr. 134 2004 1406 1411
31. E.A. Miles, T. Banerjee, and P.C. Calder The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers Prostaglandins Leukot. Essent. Fat. Acids 70 2004 529 538
32. S.L. Lemke, J.L. Vicini, H. Su, D.A. Goldstein, M.A. Nemeth, E.S. Krul, and W.S. Harris Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety Am. J. Clin. Nutr. 92 2010 766 775
33. W.S. Harris, S.L. Lemke, S.N. Hansen, D.A. Goldstein, M.A. DiRienzo, H. Su, M.A. Nemeth, M.L. Taylor, G. Ahmed, and C. George Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker Lipids 43 2008 805 811
34. M. Croset, J.C. Bordet, and M. Lagarde Inhibition of prostaglandin H synthase and activation of 12-lipoxygenase by 8,11,14,17-eicosatetraenoic acid in human endothelial cells and platelets Biochem. Pharmacol. 57 1999 631 638
35. W.S. Harris N-3 fatty acids and serum lipoproteins: human studies Am. J. Clin. Nutr. 65 1997 1645S 1654S
36. D.S. Kelley, D. Siegel, M. Vemuri, and B.E. Mackey Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men Am. J. Clin. Nutr. 86 2007 324 333
37. E.M. Balk, A.H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review Atherosclerosis 189 2006 19 30
38. W.S. Harris, B.E. Hustvedt, E. Hagen, M.H. Green, and C.A. Drevon Very long-chain omega-3 fatty acids enhance chylomicron clearance in the rat J. Lipid Res. 38 1997 503 515
39. W.S. Harris, M. Miller, A.P. Tighe, M.H. Davidson, and E.J. Schaefer Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives Atherosclerosis 197 2008 12 24
40. S. Kanji, D. Seely, F. Yazdi, J. Tetzlaff, K. Singh, A. Tsertsvadze, A.C. Tricco, M.E. Sears, T.C. Ooi, M.A. Turek, B. Skidmore, and M.T. Ansari Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review Syst. Rev. 1 2012 26 41
41. P.R. Howe, Y.K. Lungershausen, L. Cobiac, G. Dandy, and P.J. Nestel Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors J. Hum. Hypertens. 8 1994 43 49
42. E.B. Schmidt, S.D. Kristensen, R. De Caterina, and D.R. Illingworth The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia Atherosclerosis 103 1993 107 121
43. A.M. Minihane, S. Khan, E.C. Leigh-Firbank, P. Talmud, J.W. Wright, M.C. Murphy, B.A. Griffin, and C.M. Williams ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype Arterioscler. Thromb. Vasc. Biol. 20 2000 1990 1997
44. M.J. Caslake, E.A. Miles, B.M. Kofler, G. Lietz, P. Curtis, C.K. Armah, A.C. Kimber, J.P. Grew, L. Farrell, J. Stannard, F.L. Napper, A. Sala-Vila, A.L. West, J.C. Mathers, C. Packard, C.M. Williams, P.C. Calder, and A.M. Minihane Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study Am. J. Clin. Nutr. 88 2008 618 629
45. T.A. Mori, V. Burke, I.B. Puddey, G.F. Watts, D.N. O'Neal, J.D. Best, and L.J. Beilin Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men Am. J. Clin. Nutr. 71 2000 1085 1094
46. M. Suzukawa, M. Abbey, P.R. Howe, and P.J. Nestel Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages J. Lipid Res. 36 1995 473 484
47. R.J. Woodman, T.A. Mori, V. Burke, I.B. Puddey, G.F. Watts, J.D. Best, and L.J. Beilin Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients Diabetes Care 26 2003 253
48. T.A. Mori, R. Vandongen, L.J. Beilin, V. Burke, J. Morris, and J. Ritchie Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease Am. J. Clin. Nutr. 59 1994 1060 1068
49. M. Abbey, P. Clifton, M. Kestin, B. Belling, and P. Nestel Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans Arteriosclerosis 10 1990 85 94
50. H.O. Bang, J. Dyerberg, and N. Hjorne The composition of food consumed by Greenland Eskimos Acta Med. Scand. 200 1976 69 73
51. H.O. Bang, J. Dyerberg, and A.B. Nielsen Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos Lancet 1 1971 1143 1145
52. Z.S. Kaplan, and S.P. Jackson The role of platelets in atherothrombosis Hematology 1 2011 51 61
53. S. Massberg, K. Brand, S. Gruner, S. Page, E. Muller, I. Muller, W. Bergmeier, T. Richter, M. Lorenz, I. Konrad, B. Nieswandt, and M. Gawaz A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation J. Exp. Med. 196 2002 887 896
54. J. Dyerberg, and H.O. Bang Haemostatic function and platelet polyunsaturated fatty acids in Eskimos Lancet 2 1975 433 435
55. G.J. Nelson, P.C. Schmidt, G. Bartolini, D.S. Kelley, and D. Kyle The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans Lipids 32 1997 421 425
56. S.H. Goodnight Jr., W.S. Harris, W.E. Connor, and D.R. Illingworth Polyunsaturated fatty acids, hyperlipidemia, and thrombosis Arteriosclerosis 2 1982 87 113
57. W. Siess, P. Roth, B. Scherer, I. Kurzmann, B. Böhlig, and P.C. Weber Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet Lancet 1 1980 441 444
58. D. Prisco, M. Filippini, I. Francalanci, R. Paniccia, G.F. Gensini, and G.G. Serneri Effect of n-3 fatty ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions Metabolism 44 1995 562 569
59. M. Phang, L.F. Lincz, and M.L. Garg Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women J. Nutr. 143 2013 457 463
60. E. Véricel, C. Calzada, P. Chapuy, and M. Lagarde The influence of low intake of n-3 fatty acids on platelets in elderly people Atherosclerosis 147 1999 187 192
61. B.J. McEwen, M.C. Morel-Kopp, W. Chen, G.H. Tofler, and C.M. Ward Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects with cardiovascular disease Semin. Thromb. Hemost. 39 2013 25 32
62. L. Hooper, R.L. Thompson, R.A. Harrison, C.D. Summerbell, H. Moore, H.V. Worthington, P.N. Durrington, A.R. Ness, N.E. Capps, G. Davey Smith, R.A. Riemersma, and S.B. Ebrahim Omega 3 fatty acids for prevention and treatment of cardiovascular disease Cochrane Database Syst. Rev. 18 2004 CD003177
63. L.G. Gao, J. Cao, Q.X. Mao, X.C. Lu, X.L. Zhou, and L. Fan Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials Atherosclerosis 226 2013 328 334
64. F. Driss, E. Véricel, M. Lagarde, M. Dechavanne, and Ph. Darcet Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid Thromb. Res. 36 1984 389 396
65. M. Croset, E. Véricel, M. Rigaud, M. Hanss, Ph. Courpron, M. Dechavanne, and M. Lagarde Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid Thromb. Res. 57 1990 1 12
66. N. Brossard, M. Croset, C. Pachiaudi, J.P. Riou, J.L. Tayot, and M. Lagarde Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols Am. J. Clin. Nutr. 64 1996 577 586
67. N. Guillot, E. Caillet, M. Laville, C. Calzada, M. Lagarde, and E. Véricel Increasing intakes of the long chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men FASEB J. 23 2009 2909 2916
68. J.A. Conquer, and B.J. Holub Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects J. Nutr. 126 1996 3032 3039
69. S. Akiba, T. Murata, K. Kitatani, and T. Sato Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation Biol. Pharm. Bull. 23 2000 1293 1297
70. M. Lagarde Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function Prog. Lipid Res. 27 1988 135 152
71. S. Fisher, and P.C. Weber Thromboxane (TX)A3 is formed in human platelets after dietary eicosapentaenoic acid (20:5n-3) Biochem. Biophys. Res. Commun. 116 1983 1091 1099
72. S. Fisher, and P.C. Weber Thromboxane (TX)A3 and prostaglandin (PG)I3 are formed in man after dietary eicosapentaenoic acid: identification and quantification by capillary gas chromatography-electron impact mass spectrometry Biomed. Mass Spectrom. 12 1985 470 476
73. U.J. Jung, C. Torrejon, A.P. Tighe, and R.J. Deckelbaum N-3 fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clin. Nutr. 87 2008 2003S 2009S
74. B. Samuelsson Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle Acta Biol. Med. Ger. 35 1976 1055 1063
75. D. Boukhchache, and M. Lagarde Interactions between prostaglandin precursors during their oxygenation by human platelets Biochim. Biophys. Acta 713 1982 386 392
76. P.G. Swann, C.A. Parent, M. Croset, P. Fonlupt, M. Lagarde, D.L. Venton, and G.C. Le Breton Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function J. Biol. Chem. 265 1990 21692 21697
77. W.L. Smith, Y. Urade, and P.J. Jakobsson Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis Chem. Rev. 111 2011 5821 5865
78. M.K. Larson, J.H. Ashmore, K.A. Harris, J.L. Vogelaar, J.V. Pottala, M. Sprehe, and W.S. Harris Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects Thromb. Haemost. 100 2008 634 641
79. E.I. Lev, A. Solodky, A. Harel, A. Mager, D. Brosh, A. Assali, M. Roller, A. Battler, N.S. Kleiman, and R. Kornowski Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation J. Am. Coll. Cardiol. 55 2010 114 121
80. G. Gajos, P. Rostoff, A. Undas, and W. Piwowarska Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study J. Am. Coll. Cardiol. 55 2010 1671-1678
81. E. Shahar, A.R. Folsom, K.K. Wu, B.H. Dennis, T. Shimakawa, M.G. Conlan, C.E. Davis, and O.D. Williams Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler. Thromb. 13 1993 1205 1212
82. G. Gajos, J. Zalewski, P. Rostoff, J. Nessler, W. Piwowarska, and A. Undas Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot) Arterioscler. Thromb. Vasc. Biol. 31 2011 1696 1702
83. G. Kaur, D. Cameron-Smith, M. Garg, and A.J. Sinclair Docosapentaenoic acid (22:5n-3): a review of its biological effects Prog. Lipid Res. 50 2011 28 34
84. T. Hishinuma, T. Yamazaki, and M. Mizugaki Effects of long-term supplementation of eicosapentanoic and docosahexanoic acid on the 2-, 3-series prostacyclin production by endothelial cells Prostaglandins Other Lipid Mediat. 57 1999 333 340
85. C. Bénistant, F. Achard, S. Ben Salma, and M. Lagarde Docosapentaenoic acid (22:5n-3): metabolism and effect on prostacyclin production in endothelial cells Prostaglandins Leukot. Essent. Fat. Acids 55 1996 287 292
86. R. Fischer, A. Konkel, H. Mehling, K. Blossey, A. Gapelyuk, N. Wessel, C. von Schacky, R. Dechend, D.N. Muller, M. Rothe, F.C. Luft, K. Weylandt, and W.H. Schunck Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway J. Lipid Res. 55 2014 1150 1164
87. C. Arnold, M. Markovic, K. Blossey, G. Wallukat, R. Fischer, R. Dechend, A. Konkel, C. von Schacky, F.C. Luft, D.N. Muller, M. Rothe, and W.H. Schunck Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids J. Biol. Chem. 285 2010 32720 32733
88. M. Hersberger Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins Clin. Chem. Lab. Med. 48 2010 1063 1073
89. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
90. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201 2005 713 722
91. M. Spite, and C.N. Serhan Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins Circ. Res. 107 2010 1170 1184
92. M. Dona, G. Fredman, J.M. Schwab, N. Chiang, M. Arita, A. Goodarzi, G. Cheung, U.H. von Andrian, and C.N. Serhan Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes ans platelets Blood 112 2008 3848 3855
93. P. Needleman, M. Minkes, and A. Raz Thromboxanes: selective biosynthesis and distinct biological properties Science 193 1976 163 165
94. P. Needleman, A. Raz, M.S. Minkes, J.A. Ferrendelli, and H. Sprecher Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties Proc. Natl. Acad. Sci. U. S. A. 76 1979 944 948
95. N.R. Yerram, S.A. Moore, and A.A. Spector Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation J. Lipid Res. 30 1989 1747 1757
96. S. Hegde, N. Kaushal, K.C. Ravindra, C. Chiaro, K.T. Hafer, et al. Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice Blood 118 2011 6909 6919
97. J. Lefils-Lacourtablaise, M. Socorro, A. Géloën, P. Daira, C. Debard, E. Loizon, M. Guichardant, Z. Dominguez, H. Vidal, M. Lagarde, and N. Bernoud-Hubac The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism PLoS One 85 2013 e63997
98. M.O. Whitaker, A. Wyche, F. Fitzpatrick, H. Sprecher, and P. Needleman Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances Proc. Natl. Acad. Sci. U. S. A. 76 1979 5919 5923
99. H. Juan, and W. Sametz Dihomo-gamma-linolenic acid increases the metabolism of eicosapentaenoic acid in perfused vascular tissue Prostaglandins Leukot. Med. 19 1985 79 86
100. J.S. Hawkes, M.J. James, and L.G. Cleland Biological activity of prostaglandin E3 with regard to oedema formation in mice Agents Actions 35 1992 85 87
101. S.P. Tull, C.M. Yates, B.H. Maskrey, V.B. O'Donnell, J. Madden, R.F. Grimble, P.C. Calder, G.B. Nash, and G.E. Rainger Omega-3 fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment PLoS Biol. 7 2009 e1000177
102. P.C. Calder Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale Biochimie 91 2009 791 795
103. M. Croset, A. Sala, G. Folco, and M. Lagarde Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE Biochem. Pharmacol. 37 1988 1275 1280
104. P. Fonlupt, and M. Croset Lagarde M.12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets Thromb. Res. 63 1991 239 248
105. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators FASEB J. 22 2008 3595 35606
106. P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel, M. Lagarde, and M. Guichardant Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation FEBS Lett. 583 2009 3478 3484
107. P. Chen, E. Véricel, M. Lagarde, and M. Guichardant Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation FASEB J. 25 2011 382 388
108. M. Liu, T. Boussetta, K. Makni-Maalej, M. Fay, F. Driss, J. El-Benna, M. Lagarde, and M. Guichardant Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities Lipids 49 2014 49 57
109. L. Balas, M. Guichardant, T. Durand, and M. Lagarde Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date Biochimie 99 2014 1 7
110. Y. Lu, H. Tian, and S. Hong Novel 14,21-dihydroxy-docosahexaenoic Acids: Structures, Formation Pathways, and Enhancement of Wound Healing J. Lipid Res. 51 2010 923 932
111. K. Yagi Lipid peroxides and human diseases Chem. Phys. Lipids 45 1987 337 351
112. J.E. Brown, and K.W.J. Wahle Effect of fish oil and vitamin E supplementation on lipid peroxidation and whole blood aggregation in man Clin. Chim. Acta 193 1990 147 156
113. P.P. Nair, J.T. Judd, E. Berlin, P.R. Taylor, S. Shami, E. Sainz, and H.N. Bhagavan Dietary fish oil-induced changes in the distribution of alpha-tocopherol, retinol, and beta-carotene in plasma, red blood cells, and platelets: modulation by vitamin E Am. J. Clin. Nutr. 58 1993 98 102
114. D. Harats, Y. Dabach, M. Ben-Naim, R. Schwartz, E.M. Berry, O. Stein, and Y. Stein Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins Atherosclerosis 90 1991 127 139
115. I.R. Brude, C.A. Drevon, I. Hjermann, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants Arterioscler. Thromb. Vasc. Biol. 17 1997 2576 2588
116. A. Polette, D. Lemaitre, M. Lagarde, and E. Véricel N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins Thromb. Haemost. 75 1996 945 949
117. D. Lemaitre, E. Véricel, A. Polette, and M. Lagarde Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress Biochem. Pharmacol. 53 1997 479 486
118. E. Véricel, A. Polette, S. Bacot, C. Calzada, and M. Lagarde Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets J. Thromb. Haemost. 1 2003 566 572
119. C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville, E. Véricel, and M. Lagarde Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men Atherosclerosis 208 2010 467 472
120. A. Ishikado, K. Morino, Y. Nishio, F. Nakagawa, A. Mukose, Y. Sono, N. Yoshioka, K. Kondo, O. Sekine, T. Yoshizaki, S. Ugi, T. Uzu, H. Kawai, T. Makino, T. Okamura, M. Yamamoto, A. Kashiwagi, and H. Maegawa 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation PLoS One 8 2013 e69415
121. E. Giordano, and F. Visioli Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions Prostaglandins Leukot. Essent. Fat. Acids 90 2014 1 4
122. D. Richard, C. Wolf, U. Barbe, K. Kefi, P. Bausero, and F. Visioli Docosahexaenoic acid down-regulates endothelial Nox4 through as PLA2 signaling pathway Biochem. Biophys. Res. Commun. 389 2009 516 522
123. S. Mebarek, N. Ermak, A. Benzaria, S. Vicca, M. Dubois, G. Némoz, M. Laville, B. Lacour, E. Véricel, M. Lagarde, and A.F. Prigent Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis Br. J. Nutr. 1016 2009 852 858
124. T.A. Mori, D.W. Dunstan, V. Burke, K.D. Croft, J.H. Rivera, L.J. Beilin, and I.B. Puddey Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients Metabolism 48 1999 1402 1408
125. A. Benedetti, M. Comporti, R. Fulceri, and H. Esterbauer Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids Biochim. Biophys. Acta 620 1980 281 286
126. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
127. D.V. Nadkarni, and L.M. Sayre Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal Chem. Res. Toxicol. 8 1995 284 291
128. G. Jürgens, J. Lang, and H. Esterbauer Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal Biochim. Biophys. Acta 875 1986 103 114
129. S.H. Lee, and I.A. Blair Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation Chem. Res. Toxicol. 13 2000 698 702
130. S.H. Lee, T. Oc, and I.A. Blair Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 292 2001 2083 2086
131. J.A. Doorn, and D.R. Petersen Covalent adduction of nucleophilic amino acids by 4-Hydroxynonenal anl and 4-oxononenal Chem. Biol. Interact. 143 2003 93 100
132. H. Esterbauer, G. Jurgen, O. Quehenberger, and E. Koller Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes J. Lipid Res. 28 1987 495 509
133. U.P. Steinbrecher Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products J. Biol. Chem. 262 1987 3603 3608
134. E.A. Podrez, G. Hoppe, J. O'Neil, L.M. Sayre, N. Sheibani, and H.F. Hoff Macrophage receptors responsible for distinct recognition of low density lipoprotein containing pyrrole or pyridinium adducts: models of oxidized low density lipoprotein J. Lipid Res. 41 2000 1455 1463
135. S. Yamada, T. Funada, N. Shibata, M. Kobayashi, Y. Kawai, E. Tatsuda, A. Furuhata, and K. Uchida Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids J. Lipid Res. 45 2004 626 634
136. S. Collot-Teixeira, J. Martin, C. McDermott-Roe, R. Poston, and J.L. McGregor CD36 and macrophages in atherosclerosis Cardiovasc. Res. 75 2007 468 477
137. M. Guichardant, P. Taibi-Tronche, L.B. Fay, and M. Lagarde Covalent modifications of aminophospholipids by 4-hydroxynonenal Free Radic. Biol. Med. 25 1998 1049 1056
138. S. Bacot, N. Bernoud-Hubac, N. Baddas, B. Chantegrel, C. Deshayes, A. Doutheau, M. Lagarde, and M. Guichardant Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses J. Lipid Res. 44 2003 917 926
139. S. Bacot, N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, A. Doutheau, G. Ponsin, M. Lagarde, and M. Guichardant Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals J. Lipid Res. 48 2007 816 825
140. H.F. Hoff, J. O'Neil, Z. Wu, G. Hoppe, and R.L. Salomon Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 23 2003 275 282
141. R.G. Salomon, and X. Gu Critical Insights into cardiovascular disease from basic research on the oxidation of phospholipids: the 4-hydroxyalkenal phospholipid hypothesis Chem. Res. Toxicol. 24 2011 1791 1802
142. K. Ley, Y.I. Miller, and C.C. Hedrick ATVB in focus: vascular cell lineage determination and differentiation. Monocyte and macrophage dynamics during atherogenesis Arterioscler. Thromb. Vasc. Biol. 31 2011 1506 1516
143. S.O. Rahaman, D.J. Lennon, M. Febbraio, E.A. Podrez, S.L. Hazen, and R.L. Silverstein A CD36-dependent signaling cascade is necessary for macrophage foam cell formation Cell Metab. 4 2006 211 221
144. C.J. Brame, R.G. Salomon, J.D. Morrow, and L.J. Roberts II Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts J. Biol. Chem. 274 1999 13139 13146
145. N. Bernoud-Hubac, S.S. Davies, O. Boutaud, T.J. Montine, and L.J. Roberts II Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway J. Biol. Chem. 276 2001 30964 30970
146. N. Bernoud-Hubac, and L.J. Roberts II Identification of oxidized derivatives of neuroketals Biochemistry 41 2002 11466 11471
147. L. Guo, Z. Chen, B.E. Cox, V. Amarnath, R.F. Epand, R.M. Epand, and S.S. Davies Phosphatidylethanolamines modified by γ-ketoaldehyde (γKA) induce endoplasmic reticulum stress and endothelial activation J. Biol. Chem. 286 2011 18170 18180
148. L. Guo, Z. Chen, V. Amarnath, and S.S. Davies Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation Free Radic. Biol. Med. 53 2012 1226 1238
149. C.B. Sullivan, E. Matafonova, L.J. Roberts II, V. Amarnath, and S.S. Davies Isoketals form cytotoxic phosphatidylethanolamine adducts in cells J. Lipid Res. 51 2010 999 1009
150. N. Bernoud-Hubac, L.B. Fay, V. Armarnath, M. Guichardant, S. Bacot, S.S. Davies, L.J. Roberts II, and M. Lagarde Covalent binding of isoketals to ethanolamine phospholipids Free Radic. Biol. Med. 37 2004 1604 1611
151. N. Bernoud-Hubac, D.A. Alam, J. Lefils, S.S. Davies, V. Amarnath, M. Guichardant, L.J. Roberts II, and M. Lagarde Low concentrations of reactive gamma-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation Biochim. Biophys. Acta 1791 2009 307 313
152. R.G. Salomon, E. Batyreva, K. Kaur, D.L. Sprecher, M.J. Schreiber, J.W. Crabb, M.S. Penn, A.M. DiCorletoe, S.L. Hazen, and E.A. Podrez Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway Biochim. Biophys. Acta 1485 2000 225 235
153. I.G. Stavrovskaya, S.V. Baranov, X. Guo, S.S. Davies, L.J. Roberts II, and B.S. Kristal Reactive gamma-ketoaldehydes formed via the isoprostane pathway disrupt mitochondrial respiration and calcium homeostasis Free Radic. Biol. Med. 49 2010 567 579
154. D. Pratico, E.M. Smyth, F. Violi, and G.A. FitzGerald Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms J. Biol. Chem. 271 1996 4916 14924
155. L. Gao, H. Yin, G.L. Milne, N.A. Porter, and J.D. Morrow Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid J. Biol. Chem. 81 2006 14092 14099
156. L.J. Roberts II, and G.L. Milne Isoprostanes J. Lipid Res. 50 2009 S219 S223
157. L.J. Roberts, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, W.D. Dettbarn, and J.D. Morrow Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid J. Biol. Chem. 273 1998 3605 13612
158. C. Gladine, J.W. Newman, T. Durand, T.L. Pedersen, J.-M. Galano, C. Demougeot, O. Berdeaux, E. Pujos-Guillot, A. Mazur, and B. Comte Lipid profiling following Intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention PLoS One 9 2014 e89393
159. K. Strassburg, A.M. Huijbrechts, K.A. Kortekaas, J.H. Lindeman, T.L. Pedersen, A. Dane, R. Berger, A. Brenkman, T. Hankemeier, J. van Duynhoven, E. Kalkhoven, J.W. Newman, and R.J. Vreeken Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery Anal. Bioanal. Chem. 404 2012 1413 1426
160. P. Le Faouder, V. Baillif, I. Spreadbury, J.P. Motta, P. Rousset, G. Chêne, C. Guigné, F. Tercé, S. Vanner, N. Vergnolle, J. Bertrand-Michel, M. Dubourdeau, and N. Cenac LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 932 2013 123 133
161. M. Giera, A. Ioan-Facsinay, R. Toes, F. Gao, J. Dalli, A.M. Deelder, C.N. Serhan, and O.A. Mayboroda Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS Biochim. Biophys. Acta 2012 1821 1415 1424
162. J. Lang, C. Celetto, and H. Esterbauer Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance chromatography Anal. Biochem. 150 1985 369 378
163. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol. 186 1990 407 421
164. T.C. Murphy, V. Amarnath, and M.J. Picklo Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex J. Neurochem. 84 2003 1313 1321
165. G.A. Cordis, D.K. Das, and W. Riedel High-performance liquid chromatographic peak identification of 2,4-dinitrophenylhydrazine derivatives of lipid peroxidation aldehydes by photodiode array detection J. Chromatogr. A 798 1998 117 123
166. F.J. Van Kuijk, L.L. Holte, and E.A. Dratz 4-Hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid 1043 1990 116 118
167. Y. Kawai, S. Takeda, and J. Terao Lipidomic analysis for lipid peroxidation-derived aldehydes using gas chromatography-mass spectrometry Chem. Res. Toxicol. 20 2007 99 107
168. M. Guichardant, B. Chantegrel, C. Deshayes, A. Doutheau, P. Molière, and M. Lagarde Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids Biochem. Soc. Trans. 32 2004 139 140
169. B. Zarrouki, A.F. Soares, M. Guichardant, M. Lagarde, and A. Géloën The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell FEBS Lett. 581 2007 2394 2400
170. E.K. Long, I. Smoliakova, A. Honzatko, and M.J. Picklo Structural characterization of alpha, beta-unsaturated aldehydes by gc/miss dependent upon ionization methods Lipids 43 2008 765 774
171. M. Awada, C.O. Soulage, A. Meynier, C. Debard, P. Plaisancié, B. Benoit, G. Picard, E. Loizon, M.A. Chauvin, M. Estienne, N. Peretti, M. Guichardant, M. Lagarde, C. Genot, and M.C. Michalski Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells J. Lipid Res. 53 2012 2069 2080
172. M. Wang, H. Fang, and X. Han Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization Anal. Chem. 84 2012 4580 4586
173. N. Bernoud-Hubac, S.S. Davies, O. Boutaud, and L.J. Roberts II Analysis of neuroketals protein adducts by liquid chromatography electrospray ionization tandem mass spectrometry K. Hensley, R.A. Floyd, Apoptosis Methods in Pharmacology and Toxicology: Methods in Biological Oxidative Stress 2003 117 125